SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs. Mediterr J Hematol Infect Dis 2014, 6 (1), e2014003. https://doi.org/10.4084/mjhid.2014.003.